Zentalis Pharmaceuticals, Inc. (ZNTL) Stock Ticker
ZNTL right now
Market factors today
Unlock the full ZNTL picture
About Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
ZNTL stock facts
| Ticker symbol | ZNTL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $192.2M |
| CEO | Julia Marie Eastland |
| Employees | 106 |
| Headquarters | San Diego, CA, US |
| IPO date | 2020-04-03 |
| Website | www.zentalis.com |
What you can see for ZNTL on Tickr
Live ZNTL price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ZNTL report.
Rankings
FAQ
What is the ticker symbol for Zentalis Pharmaceuticals, Inc.?
The ticker symbol for Zentalis Pharmaceuticals, Inc. is ZNTL, listed on the NASDAQ.
What is ZNTL?
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations.…